Novavax’s COVID-19 booster is now authorized in Europe

marketwatch
September 12, 2022
3:54 pm
Marketwatch

Shares of Novavax Inc. NVAX, +0.32% were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax’s stock has declined 77.3% so far this year, while the S&P 500 SPX, +0.78% is down 14.6%.

Source: Marketwatch

AUDUSD consolidates ahead of US inflation report

The AUDUSD pair remains under downward pressure, trading within a range amid expectations of RBA policy easing and the upcoming US inflation data. The rate

Yen under pressure again as USDJPY challenges new highs

The Japanese yen continues to lose ground against the US dollar, with the USDJPY pair approaching its record high near 153.26. Find out more in

EURUSD Wave Analysis – 24 October 2025

EURUSD: ⬆️ Buy – EURUSD reversed from support zone – Likely to rise to resistance level 1.1740 EURUSD currency pair recently reversed up from the support

Novavax’s COVID-19 booster is now authorized in Europe

Related Posts

AUDUSD consolidates ahead of US inflation report

Yen under pressure again as USDJPY challenges new highs

EURUSD Wave Analysis – 24 October 2025

Recent Posts

Leading Key

About

Brokers By Regulator

Forex Brokers List

Trading Tools